VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in VivoSim Labs, INC. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +1 vs. Q1 2026
- Shares held
- 103.3K
- +5.38K (+5.5%) vs. Q1 2026
- Total value
- $109.7K
- −$30.3K (−21.6%) vs. Q1 2026
- New holders
- 4
- 2 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $109.7K |
| Q1 2026 | 24 | $140.0K |
| Q4 2025 | 27 | $189.3K |
| Q3 2025 | 29 | $644.4K |
| Q2 2025 | 26 | $189.0K |
| Q1 2025 | 23 | $142.6K |
| Q4 2024 | 32 | $1.15M |
| Q3 2024 | 31 | $1.24M |
| Q2 2024 | 34 | $1.77M |
| Q1 2024 | 34 | $911.7K |
| Q4 2023 | 36 | $932.1K |
| Q3 2023 | 34 | $894.3K |
| Q2 2023 | 36 | $1.35M |
| Q1 2023 | 39 | $1.76M |
| Q4 2022 | 42 | $2.64M |
| Q3 2022 | 43 | $4.07M |
| Q2 2022 | 44 | $3.43M |
| Q1 2022 | 39 | $7.42M |
| Q4 2021 | 48 | $8.23M |
| Q3 2021 | 43 | $14.9M |
| Q2 2021 | 51 | $21.4M |
| Q1 2021 | 46 | $23.1M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding VivoSim Labs, INC.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| FNY Investment Advisers, LLC | 200 | $0 | 0.00% | +200 | New |
| Harbour Investments, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| First Command Advisory Services, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Hilton Head Capital Partners, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Golden State Wealth Management, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 2 | $2 | 0.00% | 00.0% | Unchanged |
| IFG Advisory, LLC | 14 | $15 | 0.00% | +14 | New |
| Caitong International Asset Management Co., Ltd | 17 | $18 | 0.00% | +14+466.7% | Added |
| UBS Group AG | 18 | $20 | 0.00% | −934−98.1% | Reduced |
| Morgan Stanley | 49 | $52 | 0.00% | −1−2.0% | Reduced |
| Advisor Group Holdings, Inc. | 84 | $88 | 0.00% | −11−11.6% | Reduced |
| Wells Fargo & Company | 111 | $119 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 159 | $171 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 166 | $178 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 221 | $236 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,249 | $5.62K | 0.00% | +2,941+127.4% | Added |
| Vanguard Fiduciary Trust Co | 7,003 | $7.49K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 11,817 | $12.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 15,371 | $16.4K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 18,319 | $19.0K | 0.00% | +18,319 | New |
| Renaissance Technologies LLC | 18,500 | $19.8K | 0.00% | +18,500 | New |
| Geode Capital Management, LLC | 25,976 | $27.8K | 0.00% | −10,874−29.5% | Reduced |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −16,072−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −6,504−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −208−100.0% | Sold out |